Photoactivable sphingosine as a tool to study membrane microenvironments in cultured cells[S]

• Main Authors: Massimo Aureli, Simona Prioni, Laura Mauri, Nicoletta Loberto, Riccardo Casellato, Maria Grazia Ciampa, Vanna Chigorno, Alessandro Prinetti, Sandro Sonnino
• Format: Article
• Language: English
• Published: Elsevier 2010-04-01
• Series: Journal of Lipid Research
• Subjects: gangliosides; lipid rafts; membranes; Niemann-Pick disease; sphingolipids; sphingomyelin
• Online Access: http://www.sciencedirect.com/science/article/pii/S0022227520304892

Human fibroblasts from normal subjects and Niemann-Pick A (NPA) disease patients were fed with two labeled metabolic precursors of sphingomyelin (SM), [3H]choline and photoactivable sphingosine, that entered into the biosynthetic pathway allowing the synthesis of radioactive phosphatidylcholine and SM, and of radioactive and photoactivable SM ([3H]SM-N3). Detergent resistant membrane (DRM) fractions prepared from normal and NPA fibroblasts resulted as highly enriched in [3H]SM-N3. However, lipid and protein analysis showed strong differences between the two cell types. After cross-linking, different patterns of SM-protein complexes were found, mainly associated with the detergent soluble fraction of the gradient containing most cell proteins. After cell surface biotinylation, DRMs were immunoprecipitated using streptavidin. In conditions that maintain the integrity of domain, SM-protein complexes were detectable only in normal fibroblasts, whereas disrupting the membrane organization, these complexes were not recovered in the immunoprecipitate, suggesting that they involve proteins belonging to the inner membrane layer. These data suggest that differences in lipid and protein compositions of these cell lines determine specific lipid-protein interactions and different clustering within plasma membrane. In addition, our experiments show that photoactivable sphingolipids metabolically synthesized in cells can be used to study sphingolipid protein environments and sphingolipid-protein interactions.